ArticlePreventive medicine reports2024
Legislative incapacity and underreporting of COVID-19 mortality.
Article in Preventive medicine reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Leading the next pandemics.Public health in practice (Oxford, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalent interpretation of COVID-19 mortality underreporting typically focuses on authoritarian regimes' propensity for data manipulation. This study, however, posits that the demand side is integral to enhancing the veracity of COVID-19 mortality figures. Through quantitative analysis, it is demonstrated that legislative oversight of the executive significantly correlates with the divergence between excess mortality and officially reported COVID-19 mortality. Moreover, such oversight is shown to bolster the influence of bureaucratic capacity on the precision of mortality data. Consequently, these findings suggest that the notion of "autocratic advantage" in COVID-19 management is not solely a byproduct of regime-led data falsification but also a reflection of deficiencies in legislative and bureaucratic capacities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.